Sign in

CIK 0000914475 · Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330525145
Phone
(858) 617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-13 ROBERTS EIRY Chief Medical Officer Option exercise 10b5-1 +1,372 36,140
2025-02-13 ROBERTS EIRY Chief Medical Officer Option exercise · Restricted Stock Unit 10b5-1 −2,113 4,227
2025-02-13 ROBERTS EIRY Chief Medical Officer Option exercise · Restricted Stock Unit 10b5-1 −1,120 3,363
2025-02-13 ROBERTS EIRY Chief Medical Officer Option exercise · Restricted Stock Unit 10b5-1 −1,372 4,115
2025-02-13 Onyia Jude Chief Scientific Officer Option exercise 10b5-1 +2,717 18,278
2025-02-13 Onyia Jude Chief Scientific Officer Sale 10b5-1 −1,432 $116.83 $167K 16,846
2025-02-13 Onyia Jude Chief Scientific Officer Option exercise 10b5-1 +2,690 19,536
2025-02-13 Onyia Jude Chief Scientific Officer Sale 10b5-1 −1,447 $116.75 $169K 18,089
2025-02-13 Onyia Jude Chief Scientific Officer Option exercise · Restricted Stock Unit 10b5-1 −2,717 5,434
2025-02-13 Onyia Jude Chief Scientific Officer Option exercise · Restricted Stock Unit 10b5-1 −2,690 8,070
2025-02-13 Lippoldt Darin Chief Legal Officer Option exercise 10b5-1 +2,083 43,572
2025-02-13 Lippoldt Darin Chief Legal Officer Sale 10b5-1 −1,098 $116.76 $128K 42,474
2025-02-13 Lippoldt Darin Chief Legal Officer Option exercise 10b5-1 +2,017 44,491
2025-02-13 Lippoldt Darin Chief Legal Officer Sale 10b5-1 −1,086 $116.75 $127K 43,405
2025-02-13 Lippoldt Darin Chief Legal Officer Option exercise · Restricted Stock Unit 10b5-1 −2,083 4,166
2025-02-13 Lippoldt Darin Chief Legal Officer Option exercise · Restricted Stock Unit 10b5-1 −2,017 6,053
2025-02-13 Gano Kyle Chief Executive Officer Option exercise 10b5-1 +2,566 140,224
2025-02-13 Gano Kyle Chief Executive Officer Sale 10b5-1 −1,352 $116.84 $158K 138,872
2025-02-13 Gano Kyle Chief Executive Officer Option exercise 10b5-1 +2,241 141,113
2025-02-13 Gano Kyle Chief Executive Officer Sale 10b5-1 −1,206 $116.86 $141K 139,907

Page 21 of 49 · 963 trades